Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

GeneReach Biotechnology Corp. (4171) Income Statement

GeneReach Biotechnology Corp. Income Statement

Last quarter (Q2 2026), GeneReach Biotechnology Corp.'s total revenue was NT$60.02M, an increase of 10.14% from the same quarter last year. In Q2, GeneReach Biotechnology Corp.'s net income was NT$-3.88M. See GeneReach Biotechnology Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 232.74MNT$ 206.49MNT$ 225.46MNT$ 750.02MNT$ 1.01B
NT$ 160.93MNT$ 118.28MNT$ 27.58MNT$ 490.07MNT$ 746.98M
NT$ 240.79MNT$ 249.49MNT$ 256.87MNT$ 249.86MNT$ 259.57M
Depreciation and AmortizationNT$ 71.10MNT$ 74.73MNT$ 68.89MNT$ 65.17MNT$ 60.01M
NT$ -8.77MNT$ -36.31MNT$ -143.69MNT$ 343.02MNT$ 540.70M
NT$ -79.86MNT$ -131.22MNT$ -229.28MNT$ 277.85MNT$ 480.69M
NT$ -36.60MNT$ 14.24MNT$ 10.94MNT$ -5.48MNT$ -18.04M
NT$ -116.47MNT$ -116.98MNT$ -218.34MNT$ 272.37MNT$ 469.37M
NT$ -110.28MNT$ -118.73MNT$ -166.27MNT$ 221.34MNT$ 376.62M
Per Share Metrics
Basic EPSNT$ -1.93NT$ -2.08NT$ -2.89NT$ 3.85NT$ 6.55
Diluted EPSNT$ -1.93NT$ -2.08NT$ -2.89NT$ 3.77NT$ 6.45
Weighted Average Shares Outstanding57.14M57.46M57.46M57.46M57.46M
Weighted Average Shares Outstanding (Diluted)57.14M57.46M57.46M59.29M58.63M

Currency in TWD

GeneReach Biotechnology Corp. Earnings and Revenue History

-600M0600M1.2B-100 %-50 %0 %50 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin